{"id": "1356838934278471686", "creation": 1612330585.0, "user_id": "273063195", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 0, "like_count": 13, "quote_count": 0}}, "text": "Safety and efficacy of replication deficient adenovirus Sputnik V #COVID19 #vaccine. Shows 92% efficacy in interim results from a phase 3 trial. After 2nd dose, of 20.000, 16 (0,1%) were diagnosed in the vaccine group vs 62 (1,3%) in the placebo group.  https://t.co/i74sd3FpMT", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}